Home Cellular science Corbevax and ZyCoV-D – Things to keep in mind before taking your children for the COVID-19 vaccination

Corbevax and ZyCoV-D – Things to keep in mind before taking your children for the COVID-19 vaccination

0
  • The Indian government has approved a second COVID-19 vaccine for children.
  • The government would accept school ID cards for childhood vaccinations.
  • Now children over the age of 12 can register for the COVID-19 vaccination.

Disclaimer: This article should not be considered medical advice.

The Indian government has approved a second Covid-19 vaccine for children, almost a month after the official launch of the vaccination campaign for adolescents aged 15 to 18. This measure will allow children over the age of 12 to be vaccinated against COVID-19.

The government would accept school ID cards for the vaccination of children, therefore children without Aadhaar cards will also be able to get vaccinated.

This comes as a sign of relief for parents who were worried about the delay in vaccinating their children. Teenagers can request the vaccination dose on the CoWin app.

But before you take your kids to get vaccinated, these are the things you need to know.

ZyCoV-D is needle free

Age range: 15-18

The Zydus ZyCov-D vaccine was the first COVID-19 vaccine – the fifth vaccine overall – to be approved in India for children. The vaccine was available for adolescents aged 15 to 18, from January 3, 2022.

Unlike other vaccines, ZyCov-D is needle-free. It is injected using a needleless applicator called a PharmaJet which uses a narrow jet of liquid to penetrate the skin and deliver the jab.

It is also a plasmid – a type of DNA found mainly in bacteria – that provides the spike protein of the SARS-CoV-2 virus and elicits an immune response mediated by the cellular and humoral arms of the human immune system.

“The plasmid DNA platform also allows for the rapid generation of new constructs to deal with mutations in the virus, such as those that are already occurring,” Cadila Healthcare, the vaccine’s maker, told the government in August 2021.

Corbevax is a COVID-19 protein subunit vaccine

Age range: 12-18

Corbevax is the first locally developed COVID-19 protein subunit vaccine in India, which includes parts of a virus that stimulate an immune system.

“CORBEVAX is a ‘recombinant protein subunit’ vaccine, developed from a component of the spike protein on the surface of the virus, which helps the body mount the immune response against the virus,” Biological explained. E Limited, the manufacturer of the vaccine. .

The vaccine was developed by Biological E Limited in collaboration with the Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) and Baylor College of Medicine (Baylor) in Houston, Texas.

SEE ALSO

Vedanta, Reliance, Airtel and other hot stocks on Feb. 22 as the Russia-Ukraine crisis spooks global markets

Putin orders Russian troops into eastern Ukraine for ‘peacekeeping’ operation, major escalation to war

Fans mourn the end of ‘Arthur’ after 25 years of life lessons and a bunch of iconic memes